In a study published in Nature Communications biophysicists unravel the mystery of how muscles form at the molecular level and maintain their function. The findings may help design treatments for ...

Our DNA is under constant threat. Chemicals, radiation and the everyday errors of cell division all damage it, and if left ...

Muscle turns chemical energy into movement. It is able to produce force smoothly and reliably, even though it is built from ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that the U.S. Food and Drug ...

Biophysicists unraveled a mystery of how muscles form at the molecular level and how they maintain their function.

Aging muscles may not lose the signals needed for repair. Instead, those signals may remain in place but become chemically ...

A Phase III trial found the donor-derived cell therapy deramiocel slowed arm muscle decline in boys and young men with advanced Duchenne muscular dystrophy.

A panel of experts today voted against Capricor’s cell therapy for Duchenne muscular dystrophy (DMD), capping off an advisory ...

At a contentious meeting with possible implications for other rare disease drugmakers, outside experts ultimately determined that Capricor didn't prove deramiocel's benefits in Duchenne-related ...

A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that The Lancet has published full results of its ADVANCE OUTCOMES study, available here. Ralinepag has ...

Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings----Randomized, Double-Blind, ...